Phibro Animal Health | PAHC - Interest Expense On Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Phibro Animal Health

Phibro Animal Health reported $4.63M in Interest Expense on Debt for its fiscal quarter ending in December of 2022.


Interest Expense On Debt Change
ANI Pharmaceuticals ANIP:US USD 7.7M 190K
Bristol-Myers Squibb BMY:US USD 288M 6M
Canopy Growth Corp WEED:CN CAD 33.29M 2.82M
Eli Lilly LLY:US USD 102.8M 18.8M
Endo International ENDP:US USD 263K 540K
Henry Schein HSIC:US USD 14M 3M
Idexx Laboratories IDXX:US USD 13.13M 420K
Knight Therapeutics Inc GUD:CN CAD 2.79M 498K
Nektar Therapeutics NKTR:US USD 6.4M 796K
Pacira PCRX:US USD 9.59M 1.45M
Patterson Companies PDCO:US USD 9.73M 2.19M
Supernus Pharmaceuticals SUPN:US USD 1.19M 22K
Zoetis ZTS:US USD 63M 1000K